Logo image of ABI.BR

ANHEUSER-BUSCH INBEV SA/NV (ABI.BR) Stock Fundamental Analysis

EBR:ABI - Euronext Brussels - BE0974293251 - Common Stock - Currency: EUR

57.6  +0.82 (+1.44%)

Fundamental Rating

4

Overall ABI gets a fundamental rating of 4 out of 10. We evaluated ABI against 25 industry peers in the Beverages industry. While ABI is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, ABI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ABI had positive earnings in the past year.
In the past year ABI had a positive cash flow from operations.
ABI had positive earnings in each of the past 5 years.
Each year in the past 5 years ABI had a positive operating cash flow.
ABI.BR Yearly Net Income VS EBIT VS OCF VS FCFABI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

ABI has a Return On Assets (2.83%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 7.48%, ABI is in line with its industry, outperforming 60.00% of the companies in the same industry.
ABI has a Return On Invested Capital (6.49%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for ABI is in line with the industry average of 7.46%.
The last Return On Invested Capital (6.49%) for ABI is above the 3 year average (6.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROIC 6.49%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ABI.BR Yearly ROA, ROE, ROICABI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ABI has a better Profit Margin (9.80%) than 64.00% of its industry peers.
In the last couple of years the Profit Margin of ABI has declined.
ABI has a better Operating Margin (25.87%) than 76.00% of its industry peers.
In the last couple of years the Operating Margin of ABI has declined.
Looking at the Gross Margin, with a value of 55.25%, ABI is in line with its industry, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ABI has declined.
Industry RankSector Rank
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
ABI.BR Yearly Profit, Operating, Gross MarginsABI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

ABI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ABI has less shares outstanding than it did 1 year ago.
ABI has more shares outstanding than it did 5 years ago.
ABI has a better debt/assets ratio than last year.
ABI.BR Yearly Shares OutstandingABI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABI.BR Yearly Total Debt VS Total AssetsABI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ABI has an Altman-Z score of 1.76. This is a bad value and indicates that ABI is not financially healthy and even has some risk of bankruptcy.
ABI has a Altman-Z score of 1.76. This is in the lower half of the industry: ABI underperforms 64.00% of its industry peers.
The Debt to FCF ratio of ABI is 6.45, which is on the high side as it means it would take ABI, 6.45 years of fcf income to pay off all of its debts.
ABI has a Debt to FCF ratio of 6.45. This is in the better half of the industry: ABI outperforms 68.00% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that ABI is somewhat dependend on debt financing.
The Debt to Equity ratio of ABI (0.90) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Altman-Z 1.76
ROIC/WACC1.03
WACC6.32%
ABI.BR Yearly LT Debt VS Equity VS FCFABI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

ABI has a Current Ratio of 0.70. This is a bad value and indicates that ABI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.70, ABI is doing worse than 88.00% of the companies in the same industry.
A Quick Ratio of 0.54 indicates that ABI may have some problems paying its short term obligations.
ABI has a worse Quick ratio (0.54) than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.54
ABI.BR Yearly Current Assets VS Current LiabilitesABI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.08% over the past year.
The Earnings Per Share has been decreasing by -1.83% on average over the past years.
The Revenue has been growing slightly by 0.65% in the past year.
ABI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.69% yearly.
EPS 1Y (TTM)15.08%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%7.32%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%2.54%

3.2 Future

The Earnings Per Share is expected to grow by 12.11% on average over the next years. This is quite good.
Based on estimates for the next years, ABI will show a small growth in Revenue. The Revenue will grow by 4.38% on average per year.
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y12.11%
Revenue Next Year1.73%
Revenue Next 2Y3.13%
Revenue Next 3Y3.49%
Revenue Next 5Y4.38%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABI.BR Yearly Revenue VS EstimatesABI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
ABI.BR Yearly EPS VS EstimatesABI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.64, which indicates a rather expensive current valuation of ABI.
Compared to the rest of the industry, the Price/Earnings ratio of ABI is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.88. ABI is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 17.92, which indicates a rather expensive current valuation of ABI.
ABI's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.20. ABI is around the same levels.
Industry RankSector Rank
PE 18.64
Fwd PE 17.92
ABI.BR Price Earnings VS Forward Price EarningsABI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABI indicates a somewhat cheap valuation: ABI is cheaper than 72.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABI indicates a somewhat cheap valuation: ABI is cheaper than 76.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.39
EV/EBITDA 8.63
ABI.BR Per share dataABI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABI does not grow enough to justify the current Price/Earnings ratio.
ABI's earnings are expected to grow with 12.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.52
PEG (5Y)N/A
EPS Next 2Y8.45%
EPS Next 3Y12.23%

1

5. Dividend

5.1 Amount

ABI has a yearly dividend return of 0.99%, which is pretty low.
Compared to an average industry Dividend Yield of 2.72, ABI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.45, ABI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

The dividend of ABI decreases each year by -12.03%.
Dividend Growth(5Y)-12.03%
Div Incr Years2
Div Non Decr Years3
ABI.BR Yearly Dividends per shareABI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ABI pays out 45.64% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP45.64%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
ABI.BR Yearly Income VS Free CF VS DividendABI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABI.BR Dividend Payout.ABI.BR Dividend Payout, showing the Payout Ratio.ABI.BR Dividend Payout.PayoutRetained Earnings

ANHEUSER-BUSCH INBEV SA/NV

EBR:ABI (4/30/2025, 7:00:00 PM)

57.6

+0.82 (+1.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners17.94%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap112.11B
Analysts83.13
Price Target71.02 (23.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend1.19
Dividend Growth(5Y)-12.03%
DP45.64%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.01%
Min EPS beat(2)5.76%
Max EPS beat(2)20.27%
EPS beat(4)4
Avg EPS beat(4)10.29%
Min EPS beat(4)4.3%
Max EPS beat(4)20.27%
EPS beat(8)8
Avg EPS beat(8)6.77%
EPS beat(12)10
Avg EPS beat(12)7.21%
EPS beat(16)13
Avg EPS beat(16)7.45%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)4.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-1.53%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.4%
PT rev (1m)0.21%
PT rev (3m)2.03%
EPS NQ rev (1m)-1.4%
EPS NQ rev (3m)-8.37%
EPS NY rev (1m)-0.52%
EPS NY rev (3m)-4.11%
Revenue NQ rev (1m)-0.76%
Revenue NQ rev (3m)-3.87%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 18.64
Fwd PE 17.92
P/S 2.13
P/FCF 11.39
P/OCF 8.47
P/B 1.63
P/tB N/A
EV/EBITDA 8.63
EPS(TTM)3.09
EY5.36%
EPS(NY)3.21
Fwd EY5.58%
FCF(TTM)5.06
FCFY8.78%
OCF(TTM)6.8
OCFY11.81%
SpS27
BVpS35.34
TBVpS-32.65
PEG (NY)4.52
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROCE 8.91%
ROIC 6.49%
ROICexc 6.95%
ROICexgc 96.58%
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
FCFM 18.73%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ROICexc(3y)6.43%
ROICexc(5y)6.06%
ROICexgc(3y)81%
ROICexgc(5y)72.75%
ROCE(3y)8.3%
ROCE(5y)7.79%
ROICexcg growth 3Y11.31%
ROICexcg growth 5Y15.72%
ROICexc growth 3Y4.65%
ROICexc growth 5Y2.73%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
F-Score8
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Debt/EBITDA 3.37
Cap/Depr 69.68%
Cap/Sales 6.46%
Interest Coverage 4.24
Cash Conversion 71.67%
Profit Quality 191.15%
Current Ratio 0.7
Quick Ratio 0.54
Altman-Z 1.76
F-Score8
WACC6.32%
ROIC/WACC1.03
Cap/Depr(3y)85.67%
Cap/Depr(5y)89.39%
Cap/Sales(3y)7.73%
Cap/Sales(5y)8.33%
Profit Quality(3y)163.01%
Profit Quality(5y)238.24%
High Growth Momentum
Growth
EPS 1Y (TTM)15.08%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%7.32%
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y12.11%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%2.54%
Revenue Next Year1.73%
Revenue Next 2Y3.13%
Revenue Next 3Y3.49%
Revenue Next 5Y4.38%
EBIT growth 1Y5.98%
EBIT growth 3Y2.81%
EBIT growth 5Y-1.1%
EBIT Next Year41.45%
EBIT Next 3Y16.39%
EBIT Next 5Y12.38%
FCF growth 1Y29.73%
FCF growth 3Y6.91%
FCF growth 5Y4.78%
OCF growth 1Y13.49%
OCF growth 3Y0.57%
OCF growth 5Y1.41%